Description

2-Deoxy-2-fluoro-D-glucose, a radiolabeled glucose analog, is commonly used in medical imaging techniques such as positron emission tomography (PET) scans. FDG has unique chemical properties that allow it to be taken up by cells that actively metabolize glucose, such as cancer cells or inflamed tissue. Once absorbed, FDG emits positrons that can be detected in 2-Deoxy-2-fluoro-D-glucose scans, producing images that highlight areas of high metabolic activity in the body. This makes it a useful tool for diagnosing and monitoring a variety of diseases, including cancer and neurological disorders.–20°C, 3 years (Powder)-Applications–Formula-C6H11FO5-Citation–References–CASNumber-29702-43-0-MolecularWeight-182.15-Compound Purity-98.0-SMILES-OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](F)C=O-Research_Area-Others-Solubility-H2O : 100 mg/mL (ultrasonic)-Target-Biochemical Assay Reagents-Isoform–Pathway-Others-MCE Product type-Biochemical Assay Reagents